LEADER 02468oas  22009373a 450 
001 9910216947103321
005 20251106213014.0
011   $a1556-7532
035   $a(DE-599)ZDB2592406-0
035   $a(OCoLC)46778388
035   $a(CONSER)  2005214939
035   $a(CKB)963018270129
035   $a(EXLCZ)99963018270129
100   $a20010419a19909999  sy         a
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPsychopharmacology update
210   $aProvidence, RI $cManisses Communications Group
215   $a1 online resource
300   $aRefereed/Peer-reviewed
300   $a"A monthly advisory for mental health professionals."
300   $aPublished: Hoboken, NJ : John Wiley & Sons, <2005->
311 08$a1068-5308 
517 3 $aBrown University psychopharmacology update
606   $aPsychopharmacology$vPeriodicals
606   $aPsychotropic drugs$vPeriodicals
606   $aPsychopharmacologie$vPe?riodiques
606   $aPsychotropes$vPe?riodiques
606   $aPsychopharmacology$2fast$3(OCoLC)fst01081659
606   $aPsychotropic drugs$2fast$3(OCoLC)fst01081826
606   $aPsicofarmacologia$2thub
606   $aPsicofàrmacs$2thub
608   $aPeriodicals.$2fast
608   $aPeriodicals.$2lcgft
608   $aRevistes electròniques.$2thub
615  0$aPsychopharmacology
615  0$aPsychotropic drugs
615  6$aPsychopharmacologie
615  6$aPsychotropes
615  7$aPsychopharmacology.
615  7$aPsychotropic drugs.
615  7$aPsicofarmacologia.
615  7$aPsicofàrmacs.
676   $a615
712 02$aManisses Communications Group,
801  0$bDLM
801  1$bDLM
801  2$bOCLCQ
801  2$bNSD
801  2$bEYM
801  2$bKSU
801  2$bOCLCQ
801  2$bOCLCO
801  2$bOCLCF
801  2$bOCLCO
801  2$bEUW
801  2$bOCLCO
801  2$bOCLCQ
801  2$bUK7LJ
801  2$bUKMGB
801  2$bLDP
801  2$bVT2
801  2$bTOH
801  2$bUBY
801  2$bOCLCO
801  2$bOCLCQ
801  2$bOCLCO
801  2$bOCLCQ
801  2$bUAB
801  2$bOCLCL
801  2$bSFB
801  2$bOCLCL
801  2$bCSU
801  2$bOCLCQ
906   $aJOURNAL
912   $a9910216947103321
996   $aPsychopharmacology update$92178313
997   $aUNINA